Treatment of Recurrent Hepatocellular Carcinoma with Sorafenib in a HIV/HCV Co-Infected patient in HAART: A Case Report

Treatment of Recurrent Hepatocellular Carcinoma with Sorafenib in a HIV/HCV Co-Infected patient in HAART: A Case Report

<p>Abstract</p> <p>Background</p> <p>Liver disease is the second cause of death among HIV patients receiving highly active antiretroviral therapy (HAART) in Europe. HIV patients have a high prevalence of chronic HBV (6–10%) and HCV (33%) co-infection, and accelerated pr...

Full description

Bibliographic Details
Main Authors: De Nardo Pasquale, Viscione Magdalena, Corpolongo Angela, Bellagamba Rita, Vennarecci Giovanni, Ettorre Giuseppe, Gentilotti Elisa, Tommasi Chiara, Nicastri Emanuele
Format: Article
Language:English
Published: BMC 2012-06-01
Series:Infectious Agents and Cancer
Subjects:
HAART
Sorafenib
Fosamprenavir
TDM
Hepatocarcinoma
HIV/HCV co-infection
Online Access:http://www.infectagentscancer.com/7/1/15

Internet

http://www.infectagentscancer.com/7/1/15

Similar Items